Percutaneous Coronary Intervention (PCI)

Rates of Transradial Access for STEMI PCI Examined

Rates of Transradial Access for STEMI PCI Examined

Use of transradial access for STEMI percutaneous coronary intervention increased from 2009 to 2015.

Exercise Time After Percutaneous Coronary Intervention for Angina

Exercise Time After Percutaneous Coronary Intervention for Angina

Percutaneous coronary intervention does not increase exercise time more than a placebo procedure in patients with angina and severe coronary stenosis.

Genotype-Guided Antiplatelet Therapy Post-PCI May Be Beneficial

Genotype-Guided Antiplatelet Therapy Post-PCI May Be Beneficial

Alternative antiplatelet therapy after percutaneous coronary intervention in patients with a CYP2C19 loss-of-function allele may have lower risk of MACE compared to clopidogrel.

PCI and CABG Provide Similar Intermediate-Term Outcomes in Left Main CAD

PCI and CABG Provide Similar Intermediate-Term Outcomes in Left Main CAD

By

A substudy analyzed whether PCI outcomes using second generation drug eluting stents were comparable to CABG in patients with low or intermediated complexity left main coronary artery disease.

Post-PCI MACE Risk in Women, Minorities, and White Men

Post-PCI MACE Risk in Women, Minorities, and White Men

Women and minorities undergoing PCI with everolimus-eluting stents have a risk of MACE similar to that of white men.

Vitamin D as a Means of Cardioprotection in Elective PCI

Vitamin D as a Means of Cardioprotection in Elective PCI

Vitamin D did not produce a substantial preventive effect on cardiac injury during percutaneous coronary intervention.

Bleeding Risk Reduced in Atrial Fibrillation After PCI With Dual Therapy

Bleeding Risk Reduced in Atrial Fibrillation After PCI With Dual Therapy

For patients with atrial fibrillation who undergo percutaneous coronary intervention, the risk of bleeding is lower with dual therapy vs triple therapy.

Comparison of PCI Outcomes With Bivalirudin vs Heparin Post-STEMI or NSTEMI

Comparison of PCI Outcomes With Bivalirudin vs Heparin Post-STEMI or NSTEMI

By

In patients undergoing percutaneous coronary intervention for either STEMI or NSTEMI, bivalirudin and heparin produce similar outcomes.

Which Revascularization Strategy Produces Better Outcomes in Type 1 Diabetes?

Which Revascularization Strategy Produces Better Outcomes in Type 1 Diabetes?

By

Coronary artery bypass grafting yielded better outcomes in patients with type 1 diabetes who had multivessel disease compared with percutaneous coronary intervention.

CCTA Shows Diagnostic Accuracy Post-Vascular Scaffold Implantation

CCTA Shows Diagnostic Accuracy Post-Vascular Scaffold Implantation

Coronary computed tomography angiography is an accurate method of assessing angiographic outcomes after bioresorbable vascular scaffold implantation.

Heart Stents Coated With Sildenafil May Reduce Clots, Aortic Stenosis

Heart Stents Coated With Sildenafil May Reduce Clots, Aortic Stenosis

Sildenafil-coated stents may help reduce clots.

Ischemic Outcomes in Acute Coronary Syndrome Not Affected by Gender

Ischemic Outcomes in Acute Coronary Syndrome Not Affected by Gender

Gender has no effect on the outcome of acute coronary syndrome patients undergoing percutaneous coronary intervention receiving clopidogrel, prasugrel, or ticagrelor.

Lower HbA1c Post-PCI Promotes Better Outcomes in Diabetes

Lower HbA1c Post-PCI Promotes Better Outcomes in Diabetes

By

Patients with HbA1c levels had lower 7-year incidence of major adverse cardiac and cerebrovascular events compared with patients with higher HbA1c levels.

Instantaneous Wave-Free Ratio Noninferior to Fractional Flow Reserve for Guiding PCI

Instantaneous Wave-Free Ratio Noninferior to Fractional Flow Reserve for Guiding PCI

By

Both iFR and FFR groups experienced similar rates of composite nonfatal myocardial infarction, unplanned revascularization, or all-cause death within 1 year post-procedure.

Target-Vessel Failure Rate in Scaffold vs Stent PCI

Target-Vessel Failure Rate in Scaffold vs Stent PCI

Researchers found similar rates of target-vessel failure in both scaffold and stent percutaneous coronary intervention (PCI).

ACC Updated Criteria: Coronary Revascularization in Stable Ischemic Heart Disease

ACC Updated Criteria: Coronary Revascularization in Stable Ischemic Heart Disease

By

Revised coronary revascularization criteria rated whether coronary interventions are appropriate in tables organized according to practice patterns.

Safety of Same-Day Discharge Following PCI for Non-ST Elevation ACS

Safety of Same-Day Discharge Following PCI for Non-ST Elevation ACS

By

Researchers found that same-day discharge in PCI for non-ST-segment elevation acute coronary syndromes.

Delay Between Antiplatelet Therapy And PCI Improves Coronary Reperfusion

Delay Between Antiplatelet Therapy And PCI Improves Coronary Reperfusion

By

A longer wait between administration of antiplatelet therapy and primary percutaneous intervention has been linked to improved coronary reperfusion.

Appropriate Use Criteria Application Reduces Percutaneous Coronary Intervention Incidence

Appropriate Use Criteria Application Reduces Percutaneous Coronary Intervention Incidence

Under scrutiny, incidence of PCI in New York state decreased from 18.2% to 10.6% between 2010-2014.

Evaluating Cangrelor Vs Clopidogrel In Percutaneous Coronary Intervention

Evaluating Cangrelor Vs Clopidogrel In Percutaneous Coronary Intervention

By

Researchers studied the safety and efficacy of cangrelor in patients receiving unfractionated heparin for PCI.

Target Lesion Failure and Stent Thrombosis Rates Low With SYNERGY

Target Lesion Failure and Stent Thrombosis Rates Low With SYNERGY

By

Target lesion failure was 5.8% at 1 year after implantation with the SYNERGY stent.

Same-Day Discharge Reduces Costs in Percutaneous Coronary Intervention

Same-Day Discharge Reduces Costs in Percutaneous Coronary Intervention

Same day discharge in percutaneous coronary intervention and transradial intervention has been associated with lowered costs among Medicare beneficiaries.

Does Furosemide With Matched Hydration Reduce Incidence of Contrast-Induced AKI?

Does Furosemide With Matched Hydration Reduce Incidence of Contrast-Induced AKI?

RenalGuard therapy was linked to significantly reduced incidences of contrast-induced acute kidney injury.

STEMI Mortality Reduced With Admission to Primary PCI Center

STEMI Mortality Reduced With Admission to Primary PCI Center

Direct admission to a primary percutaneous coronary intervention center for ST-segment elevation myocardial infarction was associated with lower 12-month mortality.

First-Generation Drug-Eluting Stent Outcomes After 10 Years

First-Generation Drug-Eluting Stent Outcomes After 10 Years

By

No major differences in MACE or stent thrombosis were shown between the 2 drug-eluting stents after 10 years of follow-up.

SYNTAX Scores Linked to Long-Term Revascularization Outcomes

SYNTAX Scores Linked to Long-Term Revascularization Outcomes

By

Higher SYNTAX scores may predict major cardiovascular events in patients with coronary artery disease and diabetes.

Timing of Noncardiac Surgery Following Percutaneous Coronary Intervention

Timing of Noncardiac Surgery Following Percutaneous Coronary Intervention

By

Although current guidelines recommend delaying noncardiac surgery for 6 to 12 months after drug-eluting stent implantation, new data suggest surgery may be performed earlier.

Is Routine Follow-Up Coronary Angiography Necessary After PCI?

Is Routine Follow-Up Coronary Angiography Necessary After PCI?

Routine follow-up coronary angiography has no long-term clinical benefit in patients who have undergone percutaneous coronary intervention.

PCI Outcomes at Centers With and Without On-Site Cardiac Surgery

PCI Outcomes at Centers With and Without On-Site Cardiac Surgery

By

After multivariate adjustment, no significant in-hospital mortality difference was found between centers with and without on-site cardiac surgery.

Ischemic Stroke Risk After Percutaneous Coronary Intervention

Ischemic Stroke Risk After Percutaneous Coronary Intervention

The highest relative risk of ischemic stroke after percutaneous coronary intervention was seen during the first 2 days following the procedure.

Sign Up for Free e-Newsletters